Ad is loading...
MEFNX vs PAMCX
MEFNX vs PAMCX Comparison
Open Charts MEFNX vs PAMCX
MassMutual Mid Cap Growth R3
Price$12.95
Change-$0.02 (-0.15%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$104.66
Change-$0.21 (-0.20%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VS
VS
MEFNX vs PAMCX Comparison Chart
Loading...
MEFNX vs. PAMCX commentary
Oct 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEFNX is a Buy and PAMCX is a Buy.
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.5B vs. MEFNX (5.1B). MEFNX (0.00) and PAMCX (0.00) have matching dividends . MEFNX was incepted earlier than PAMCX: MEFNX (22 years) vs PAMCX (25 years). MEFNX is a more actively managed with annual turnover of: 32.00 vs. PAMCX (21.70). MEFNX has a lower initial minimum investment than PAMCX: MEFNX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : 16.39 vs. MEFNX (14.88). PAMCX return over 5 years is better than : 15.77 vs. MEFNX (-27.26).
| MEFNX | PAMCX | MEFNX / PAMCX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 22 years | 25 years | - |
| Gain YTD | 11.522 | 10.157 | 113% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.1B | 31.5B | 16% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 14.88 | 16.39 | 91% |
| Returns for 3 years | -44.76 | -14.28 | 314% |
| Returns for 5 years | -27.26 | 15.77 | -173% |
| Returns for 10 years | -19.04 | 44.08 | -43% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GIDCX | 7.18 | N/A | N/A |
| Goldman Sachs Intl Eq Div & Prem C | |||
| WSTRX | 53.14 | N/A | N/A |
| Delaware Ivy Science and Technology R | |||
| HFESX | 45.59 | N/A | N/A |
| Janus Henderson European Focus S | |||
| CGLIX | 17.59 | N/A | N/A |
| Calvert Global Equity Fund Class I | |||
| CVMCX | 17.48 | -0.11 | -0.63% |
| Calvert Emerging Markets Equity C | |||